These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 11766248)

  • 1. Use of reversal agents in day care procedures (with special reference to postoperative nausea and vomiting).
    Fuchs-Buder T; Mencke T
    Eur J Anaesthesiol Suppl; 2001; 23():53-9. PubMed ID: 11766248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accidental intra-arterial injection of neostigmine with glycopyrrolate or atropine for reversal of residual neuromuscular blockade: a report of two cases.
    Jain A; Sahni N; Banik S; Solanki SL
    Anesth Analg; 2012 Jul; 115(1):210-1. PubMed ID: 22723211
    [No Abstract]   [Full Text] [Related]  

  • 3. Omitting antagonism of neuromuscular block: effect on postoperative nausea and vomiting and risk of residual paralysis. A systematic review.
    Tramèr MR; Fuchs-Buder T
    Br J Anaesth; 1999 Mar; 82(3):379-86. PubMed ID: 10434820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
    Sacan O; White PF; Tufanogullari B; Klein K
    Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of antagonizing residual neuromuscular blockade by neostigmine and glycopyrrolate on nausea and vomiting after ambulatory surgery.
    Joshi GP; Garg SA; Hailey A; Yu SY
    Anesth Analg; 1999 Sep; 89(3):628-31. PubMed ID: 10475292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of neostigmine and atropine combination on postoperative nausea and vomiting after arthroscopic surgery].
    Coşar A; Yildiz C; Orhun E; Yanmiş I; Ergun A; Tunay S
    Acta Orthop Traumatol Turc; 2005; 39(4):341-4. PubMed ID: 16269882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Residual paralysis: a real problem or did we invent a new disease?
    Donati F
    Can J Anaesth; 2013 Jul; 60(7):714-29. PubMed ID: 23625545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Which muscle relaxants should be used in day surgery and when.
    Bettelli G
    Curr Opin Anaesthesiol; 2006 Dec; 19(6):600-5. PubMed ID: 17093362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative residual paralysis in outpatients versus inpatients.
    Cammu G; De Witte J; De Veylder J; Byttebier G; Vandeput D; Foubert L; Vandenbroucke G; Deloof T
    Anesth Analg; 2006 Feb; 102(2):426-9. PubMed ID: 16428537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does neostigmine administration produce a clinically important increase in postoperative nausea and vomiting?
    Cheng CR; Sessler DI; Apfel CC
    Anesth Analg; 2005 Nov; 101(5):1349-1355. PubMed ID: 16243993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of sugammadex and conventional reversal on postoperative nausea and vomiting: a randomized, blinded trial.
    Koyuncu O; Turhanoglu S; Ozbakis Akkurt C; Karcıoglu M; Ozkan M; Ozer C; Sessler DI; Turan A
    J Clin Anesth; 2015 Feb; 27(1):51-6. PubMed ID: 25544263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of neuromuscular blockade in ambulatory patients.
    Schreiber JU
    Curr Opin Anaesthesiol; 2014 Dec; 27(6):583-8. PubMed ID: 25251920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Residual neuromuscular blockade: management and impact on postoperative pulmonary outcome.
    Fuchs-Buder T; Nemes R; Schmartz D
    Curr Opin Anaesthesiol; 2016 Dec; 29(6):662-667. PubMed ID: 27755128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neostigmine with glycopyrrolate does not increase the incidence or severity of postoperative nausea and vomiting in outpatients undergoing gynaecological laparoscopy.
    Nelskylä K; Yli-Hankala A; Soikkeli A; Korttila K
    Br J Anaesth; 1998 Nov; 81(5):757-60. PubMed ID: 10193290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrio-ventricular Block Following Neostigmine-Glycopyrrolate Reversal in Non-heart Transplant Patients: Case Report.
    Nkemngu NJ; Tochie JN
    Anesth Prog; 2018; 65(3):187-191. PubMed ID: 30235426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neostigmine/glycopyrrolate administered after recovery from neuromuscular block increases upper airway collapsibility by decreasing genioglossus muscle activity in response to negative pharyngeal pressure.
    Herbstreit F; Zigrahn D; Ochterbeck C; Peters J; Eikermann M
    Anesthesiology; 2010 Dec; 113(6):1280-8. PubMed ID: 20980910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Residual neuromuscular blockade: incidence, assessment, and relevance in the postoperative period.
    Murphy GS
    Minerva Anestesiol; 2006 Mar; 72(3):97-109. PubMed ID: 16493386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Edrophonium is better than neostigmine to antagonize residual vecuronium induced neuromuscular block.
    Puura AI; Baer GA; Rorarius MG
    Acta Anaesthesiol Belg; 1994; 45(4):161-6. PubMed ID: 7887118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neostigmine 50 microg kg(-1) with glycopyrrolate increases postoperative nausea in women after laparoscopic gynaecological surgery.
    Løvstad RZ; Thagaard KS; Berner NS; Raeder JC
    Acta Anaesthesiol Scand; 2001 Apr; 45(4):495-500. PubMed ID: 11300390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycopyrrolate: It's time to review.
    Howard J; Wigley J; Rosen G; D'mello J
    J Clin Anesth; 2017 Feb; 36():51-53. PubMed ID: 28183573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.